Medical Program-Wide Activities

Abstract

The Army Medical Command receives funding for research infrastructure management support requirements at select continental United States (CONUS) and outside the continental US (OCONUS) laboratories and clinical trial sites. Research scientists at these laboratories conduct bio-surveillance and early-to-late-stage clinical research of investigational products such as biologics, drugs, and devices to treat/prevent polytrauma (multiple traumatic injuries) and infectious diseases. Research is conducted to obtain US Food and Drug Administration (FDA) approval; a requirement for use of all medical products. The funding provides for the sustainment of significant technical expertise and knowledge independent of the number of assigned projects. This funding also provides for initial outfitting and transition (IO&T) cost requirements for replacement of research, development, test and evaluation (RDT&E) medical laboratories funded under multi-year military construction (MILCON) projects. These IO&T funds are designated as appropriations other than MILCON. The Office of the Assistant Secretary of Defense for Health Affairs (Force Health Protection & Readiness) receives funds to provide management support for research projects at Pacific Joint Information Technology Center (P-JITC). For the Navy Bureau of Medicine and Surgery, this program element includes facility operational funding for the Medical Biological Defense research sub-function of the Naval Medical Research Center (NMRC) Biological Defense Research Directorate (BDRD). The program mission is mandated by the Joint Requirements Office for Chemical, Biological, Radiological, and Nuclear Defense (JRO-CBRND) baseline capabilities assessment of chemical and biological passive defense. The primary function is Research on Countermeasures to Biological Threat Agents; Development of Assays to Detect Biological Threat Agents; Bioforensic Analysis of Biological Threat Agents.

Document Details

• Document Type: R2 Budgetary Justification
• Publication Date: Oct 01, 2015
• Source ID: 0606105HP_2_0130_PB_2015
• Change Summary Explanation: FY 2013: Realignment from Defense Health Program, Research, Development, Test and Evaluation (DHP RDT&E), PE 0606105-Medical Program-Wide Activities (-$0.833 million) to DHP RDT&E PE 0605502-Small Business Innovation Research (SBIR) Program (+$0.833 million). FY2013: General Congressional Reductions to DHP RDT&E, PE 0606105-Medical Program-Wide Activities (-$0.080 million). FY2013: Congressional Directed Reductions (Sequestration) to DHP RDT&E, PE 0606105-Medical Program-Wide Activities (-$30.647 million). FY 2013: Below Threshold Reprogramming (BTR) from DHP RDT&E PE, 0603115-Medical Technology Development (-$8.136 million) to DHP RDT&E PE, 0606105-Medical Program-Wide Activities (+$8.136 million). FY 2013: Below Threshold Reprogramming (BTR) from DHP RDT&E PE, 0604110-Medical Products Support and Advanced Concept Development (-$2.740 million) to DHP RDT&E PE, 0606105-Medical Program-Wide Activities (+$2.740 million). FY 2014: Realignment from Defense Health Program, Research, Development, Test and Evaluation (DHP RDT&E), PE 0606105-Medical Program-Wide Activities (-$2.033 million) to DHP RDT&E PE 0605502-Small Business Innovation Research (SBIR) Program (+$2.033 million). FY 2015: Reduces non-combat injury research funding in order to focus and continue the pace of progress in critical and high priority research areas for DHP RDT&E, PE 0606105-Medical Program-Wide Activities (-$9.495 million).
• Service Agency Name: Defense Health Program

Tags

Communities of Interest

• Biomedical

DTIC Thesaurus Topics

• Biomedical Research
• Clinical Trials
• Infectious Diseases
• Information Systems
• Infrastructure
• Medical Laboratories
• Passive Defense
• Research Facilities
• Supply Chain Management
• Test And Evaluation
• Test Facilities
• United States

Readers

• Critical Infrastructure Protection in CBRN and WMD Threats.
• Defense Financial Management and Audit.